Cytokinetics Receives Orphan Drug Status for ALS Treatment
Promising data from a Phase I clinical trial of CK-2017357 was announced in January.
Promising data from a Phase I clinical trial of CK-2017357 was announced in January.
Copyright © 2024 | WordPress Theme by MH Themes